GLP-1s could cut $30-55B food demand

GLP-1 drugs are starting to show up in a weird place — freight math. That sounds like a stretch, but it’s basically the same story seen from farther down the supply chain. If millions of people eat less, especially fewer snacks and sugary drinks, fewer cases move through warehouses, onto trucks, and into stores. The big debate is no longer whether these drugs change food demand. It’s how big the shift gets, and which companies are positioned for it. ### Why are truckers suddenly talking about Ozempic? Because food demand is freight demand. FreightWaves argued in March that appetite suppression from GLP-1 drugs could already be trimming food-and-beverage shipments, using a rough estimate of a 3% drop in caloric demand at current penetration. Run that across the U.S. food supply chain and the effect gets large fast — potentially millions fewer truckloads a year if adoption keeps climbing. That estimate is directional, not settled fact, but it explains why logistics people are paying attention. (finance.yahoo.com) ### What’s the strongest evidence underneath that? The best hard evidence is still consumer spending data, not truck counts. Cornell and Numerator found that households with at least one GLP-1 user cut grocery spending by about 5.3% to 5.5% within six months of starting the drugs. Higher-income households cut more than 8%. The sharpest pullbacks were in calorie-dense processed foods — especially savory snacks, sweets, baked goods, and soft drinks. That is exactly the mix you’d expect to pressure packaged-food volumes first. (finance.yahoo.com) ### So is this mostly a snack problem? Mostly, yes. The categories taking the clearest hit are the ones built around impulse eating and excess calories. FreightWaves highlighted processed snacks, beverages, alcohol, and refined grains as the obvious pressure points, while Purdue’s summary of the Cornell work points to savory snacks down about 11% among adopters. But the shift is not “people stop buying food.” It’s “people buy less of some food, and a different mix of the rest.” (news.cornell.edu) ### Who is already adapting? PepsiCo is one of the clearest examples. Ramon Laguarta said in early 2026 that GLP-1s create both threats and opportunities, but he emphasized that more than 70% of PepsiCo’s U.S. food business is already single-serve and said the company is investing in portion-controlled capacity, hydration, fiber, and protein. That is a pretty direct admission that the consumer is changing and the product mix has to change with them. (finance.yahoo.com) ### What about Hershey? Hershey’s latest quarter showed the same pattern from a different angle. The company said stronger demand for mints and healthier snacks helped results, and Reuters tied part of that to GLP-1-driven eating changes. Ice Breakers sales were up, and management framed the opportunity as “functional snacking” — products tied to a specific need, not just indulgence. That doesn’t mean candy is safe. It means even a confectioner is trying to move closer to utility. (dairyprocessing.com) ### Are the giant dollar estimates real? They’re plausible as scenario math, but they’re not yet the kind of figure you should treat as audited reality. The more defensible line today is this: household-level food spending is falling meaningfully among users, and GLP-1 adoption is rising fast. J.P. Morgan estimates about 10 million Americans were on branded GLP-1s in 2025 and sees roughly 25 million on treatment by 2030, helped by broader access, lower prices, and oral versions. (money.usnews.com) If that adoption curve holds, today’s grocery effect scales into something very large. ### What’s the catch in all this? The catch is that volume falls and mix shifts are not the same thing. Some companies lose outright. Others sell smaller packs, more protein, more hydration, or more “better-for-you” snacks and keep the customer. Freight gets hit differently too — fewer snack-heavy loads, but not necessarily a one-for-one collapse in total food movement if demand rotates into other categories. The pain will be uneven, not universal. (jpmorgan.com) ### Bottom line? GLP-1s are turning food demand from a health story into an operations story. The first-order effect is simple — people eat less. The second-order effect is where the money is: fewer snack cases, different baskets, different factory plans, and eventually different freight lanes. The companies that win probably won’t be the ones denying the shift. They’ll be the ones reformulating around it. (news.cornell.edu) (finance.yahoo.com)